Qantum财务顾问和其他投资者削减了在AbbVie的股份,尽管其收入很高。 Quantum Financial Advisors and other investors cut their stakes in AbbVie, despite its strong earnings.

量子金融顾问和其他机构投资者减少了在AbbVie Inc.的股份,量子将股份减少3.1%至3 478股,价值729 000美元。 Quantum Financial Advisors and other institutional investors have reduced their holdings in AbbVie Inc., with Quantum lowering its shares by 3.1% to 3,478, valued at $729,000. 创建者资本管理部门的股份减少了19.7%,现在拥有25 321股股份。 Founders Capital Management decreased its holdings by 19.7%, now owning 25,321 shares. AbbVie报告EPS为2.46美元,殴打估计数,市场上限为3 277.2亿美元。 AbbVie reported EPS of $2.46, beating estimates and has a market cap of $327.72 billion. 股价为210.95美元 The stock has a "Moderate Buy" rating and a target price of $210.95.